Concepedia

Author

Devraj Srinivasan

Western General Hospital

Also Known As

D Srinivasan, D. Srinivasan, D.P. Srinivasan, Devraj P. Srinivasan, Devraj Pamoorthy Srinivasan, Devraj Srinivasan, Dharsha Srinivasan, S Arman

28

Publications

3.8K

Citations

8

H-Index

24

Concepts

All Affiliations

Western General HospitalWeston Park Cancer CentreInstitute of Cancer ResearchRoyal Marsden HospitalCheltenham General Hospital
DS

About

Devraj Srinivasan is an author at Western General Hospital specializing in oncology, head and neck cancer, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

1.7K

2

Health Sciences

2

2

70

3

Diagnostic Sciences

1

1

32

4

Head And Neck Surgery

1

1

38

5

Pathology

1

1

1.6K

Devraj Srinivasan

×

6

Publications

2.8K

Citations

6

H-Index

YearCitations

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

Ezra E.W. Cohen, Denis Soulières, Christophe Le Tourneau,

The Lancet

2018

1.6K

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial

Hisham Mehanna, Max Robinson, A. Hartley,

The Lancet

2018

988

Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trial

Christopher M. Nutting, Laura Finneran, Justin Roe,

The Lancet Oncology

2023

93

Tyrosine Kinase Inhibitor Therapy in Locally Advanced Differentiated Thyroid Cancer: A Case Report

Kirsten Stewart, Mark W. J. Strachan, Devraj Srinivasan,

European Thyroid Journal

2019

38

Results of a randomized phase III study of dysphagia-optimized intensity modulated radiotherapy (Do-IMRT) versus standard IMRT (S-IMRT) in head and neck cancer.

Christopher M. Nutting, Keith Rooney, Bernadette Foran,

Journal of Clinical Oncology

2020

32

CompARE: study protocol for a phase III randomised controlled platform trial comparing alternative regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer

Hisham Mehanna, Piers Gaunt, Anthony Kong,

Trials

2024

16

Page 1